NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
43 hedge funds and large institutions have $10.7M invested in NeuBase Therapeutics, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 5 closing their positions.
Holders
43
Holders Change
+4
Holders Change %
+10.26%
% of All Funds
0.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
12
Reduced
7
Closed
5
Calls
$140K
Puts
$146K
Net Calls
-$6K
Net Calls Change
-$4K
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$3.04M |
2 |
2
Renaissance Technologies
New York
|
$1.95M |
3 |
WS
3
Wedbush Securities
Los Angeles,
California
|
$1.23M |
4 |
CC
4
Cannell & Co
New York
|
$915K |
5 |
5
Northern Trust
Chicago,
Illinois
|
$258K |